Geneva Partners’s ASML ASML Stock Holding History

Geneva Partners’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.75M	Buy	+1,884	New	+$3M	1%	31
2024 Q3	–	Sell	-3,285	Closed	-$3.36M	–	71
2024 Q2	$3.36M	Buy	3,285 +1,383	+73%	+$1.33M	1.38%	29
2024 Q1	$1.85M	Buy	+1,902	New	+$1.69M	0.81%	37
2023 Q3	–	Sell	-7,013	Closed	-$5.08M	–	66
2023 Q2	$5.08M	Buy	7,013 +1,877	+37%	+$1.28M	3.32%	13
2023 Q1	$3.5M	Buy	+5,136	New	+$3.3M	2.99%	13
2018 Q1	–	Sell	-5,230	Closed	-$909K	–	79
2017 Q4	$909K	Sell	5,230 -150	-3%	-$26.5K	0.68%	54
2017 Q3	$921K	Buy	+5,380	New	+$824K	0.73%	48

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geneva Partners's ASML Position: Q2 2026 in Review

Geneva Partners opened a new position in ASML (ASML) in Q2 2026: 1,884 shares worth $3.75M. The stake represents 1% of the portfolio and ranks #31 among its holdings. This is a return to the name: Geneva Partners previously reported a position in ASML as recently as Q2 2024.

Geneva Partners first reported a position in ASML in Q3 2017 and has held it in 7 quarters since. The position peaked at $5.08M in Q2 2023. 2,510 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Geneva Partners held 1,884 shares of ASML worth $3.75M as of Q2 2026.
ASML was a new Geneva Partners position in Q2 2026.
ASML made up 1% of Geneva Partners's portfolio in Q2 2026, its #31 holding.
Geneva Partners first reported a position in ASML in Q3 2017 and has held it in 7 quarters since.
Geneva Partners's ASML position peaked at $5.08M in Q2 2023.
2,510 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Geneva Partners's 13F filing for Q2 2026, filed 10 Aug 2026.